Earlier this month the Food and Drug Administration (FDA) authorized the mRNA vaccine for emergency use in young children, aged six months to five years old, after its advisory committee voted in favor of the experimental treatment, claiming that it has passed its clinical hurdles and is effective in preventing symptomatic infection without causing worrisome side effects.
However, in addition to ignoring the mountain of evidence showing the vaccines are regularly causing life-threatening injuries – especially in healthy children and young people, the FDA ‘experts’ have routinely skipped crucial steps in the testing process, allowing them to manipulate the data in order to suit their desired outcomes.
This inexcusable act of criminal malpractice was confirmed this month by the team leader of the FDA’s clinical review staff, Rachel Zhang, who explained during an advisory panel zoom call that the agency had lost the results from the placebo group during its clinical trials related to the decision to approve the experimental jab for America’s youngest children.
Without this data from the placebo group, the effectiveness of the vaccine cannot be measured against those who did not receive the treatment. Therefore, the clinical trial is meaningless. But the gaping hole in the results apparently doesn’t matter to the ‘experts’ at the FDA, who went ahead with the EUA approval anyway.